Bank Of America Corp Galectin Therapeutics Inc Transaction History
Bank Of America Corp
- $1.12 Trillion
- Q2 2024
A detailed history of Bank Of America Corp transactions in Galectin Therapeutics Inc stock. As of the latest transaction made, Bank Of America Corp holds 18,356 shares of GALT stock, worth $55,068. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,356
Previous 14,733
24.59%
Holding current value
$55,068
Previous $35,000
17.14%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding GALT
# of Institutions
78Shares Held
9.37MCall Options Held
982KPut Options Held
2.7K-
Vanguard Group Inc Valley Forge, PA2.12MShares$6.35 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.56MShares$4.69 Million0.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ1.13MShares$3.38 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA842KShares$2.53 Million0.0% of portfolio
-
Commonwealth Equity Services, LLC483KShares$1.45 Million0.0% of portfolio
About GALECTIN THERAPEUTICS INC
- Ticker GALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,426,000
- Market Cap $178M
- Description
- Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial f...